Investor Alert

New York Markets Close in:

Lipocine Inc.

NAS: LPCN

GO
/marketstate/country/us

Market open

 --Quotes are delayed by 20 min

Sep 29, 2022, 10:10 a.m.

/zigman2/quotes/202742746/composite

$

0.43

Change

+0.0096 +2.28%

Volume

Volume 75,934

Quotes are delayed by 20 min

/zigman2/quotes/202742746/composite

Previous close

$ 0.42

$ 0.43

Change

+0.0096 +2.28%

Day low

Day high

$0.41

$0.44

Open

52 week low

52 week high

$0.36

$1.89

Open

Richard Dana Ono

Founder of VIMAC Milestone Medica Fund LP and IntraImmune Therapies, Inc., Richard Dana Ono currently occupies the position of Managing Director at VIMAC Ventures LLC. Dr. Ono is also on the board of Massachusetts Biotechnology Council, Lipocine, Inc. and Inhibitor Therapeutics, Inc. and Member of Explorer’s Club.

In the past Dr. Ono occupied the position of President & Chief Executive Officer at IntraImmune Therapies, Inc.

He received an undergraduate degree from The Johns Hopkins University and a doctorate and a graduate degree from Harvard University.

Transactions

Date Shares Transaction Value
12/16/2020 5,250   Derivative/Non-derivative trans. at $0 per share. 0
12/29/2017 875   Disposition at $3.47 per share. 3,037
12/29/2017 1,750   Derivative/Non-derivative trans. at $0 per share. 0

Officers and Executives

Dr. Mahesh V. Patel
Chairman, President, Chief Executive Officer & CFO
Dr. Anthony DelConte
Chief Medical Director
Dr. Nachiappan Chidambaram
Vice President-Product Development
Mr. John W. Higuchi
Director
Ms. Krista Fogarty
Chief Accounting Officer
Mr. Hans Vitzthum
Head-Investors Relation Contact
Dr. Jill M. Jene
Independent Director
Dr. Spyros Papapetropoulos
Independent Director
Dr. Richard Dana Ono
Independent Director
Mr. Jeffrey Arvin Fink
Independent Director
Link to MarketWatch's Slice.